11.22
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Perrigo Company Plc stock is traded at $11.22, with a volume of 2.28M.
It is down -1.15% in the last 24 hours and down -5.08% over the past month.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
See More
Previous Close:
$11.35
Open:
$11.42
24h Volume:
2.28M
Relative Volume:
0.70
Market Cap:
$1.55B
Revenue:
$4.18B
Net Income/Loss:
$-1.79B
P/E Ratio:
-0.8562
EPS:
-13.1048
Net Cash Flow:
$107.70M
1W Performance:
+5.75%
1M Performance:
-5.08%
6M Performance:
-11.23%
1Y Performance:
-57.50%
Perrigo Company Plc Stock (PRGO) Company Profile
Name
Perrigo Company Plc
Sector
Phone
269-673-8451
Address
THE SHARP BUILDING, DUBLIN 2
Compare PRGO vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PRGO
Perrigo Company Plc
|
11.22 | 1.57B | 4.18B | -1.79B | 107.70M | -13.10 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-14-25 | Downgrade | Argus | Buy → Hold |
| Jan-06-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-24-24 | Resumed | Jefferies | Hold |
| Nov-17-23 | Initiated | Piper Sandler | Overweight |
| Mar-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-14-22 | Upgrade | Argus | Hold → Buy |
| Sep-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-14-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-30-21 | Upgrade | Jefferies | Hold → Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Jan-06-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-17-20 | Downgrade | Argus | Buy → Hold |
| Mar-24-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-20-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-18-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-11-19 | Upgrade | Argus | Hold → Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Nov-13-18 | Downgrade | Berenberg | Buy → Hold |
| Aug-10-18 | Reiterated | Stifel | Hold |
| Jul-30-18 | Downgrade | Argus | Buy → Hold |
| Jul-12-18 | Downgrade | Goldman | Neutral → Sell |
| Jan-03-18 | Initiated | Leerink Partners | Mkt Perform |
| Dec-08-17 | Upgrade | Argus | Hold → Buy |
| Nov-10-17 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Oct-05-17 | Reiterated | UBS | Buy |
| Sep-07-17 | Initiated | Oppenheimer | Outperform |
| Aug-11-17 | Upgrade | Goldman | Sell → Neutral |
| Aug-11-17 | Reiterated | RBC Capital Mkts | Underperform |
| Jun-16-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-05-17 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform |
| Mar-03-17 | Reiterated | B. Riley & Co. | Neutral |
View All
Perrigo Company Plc Stock (PRGO) Latest News
Perrigo Q1 earnings surpass estimates, sales miss, both fall Y/Y - MSN
Compeed Blister Plasters for Active Feet Explained - AD HOC NEWS
Perrigo Co. PLC stock underperforms Friday when compared to competitors - MarketWatch
[Form 4] PERRIGO Co plc Insider Trading Activity - Stock Titan
Perrigo (NYSE: PRGO) CEO receives 173,837 RSUs in new equity grant - Stock Titan
Perrigo (PRGO) CFO awarded 52,678 RSUs, now holds 77,760 ordinary shares - Stock Titan
Perrigo (NYSE: PRGO) awards 31,607 RSUs to EVP and CSO - Stock Titan
Perrigo (NYSE: PRGO) awards 42,142 RSUs to EVP Roberto Khoury - Stock Titan
Perrigo (PRGO) EVP & CBDO David Ball awarded 26,339 RSUs - Stock Titan
Perrigo (NYSE: PRGO) EVP & CHRO receives 22,388 RSU award - Stock Titan
Perrigo (NYSE: PRGO) awards EVP 22,388 restricted stock units - Stock Titan
Perrigo (PRGO) EVP and General Counsel receives grant of 46,093 RSUs - Stock Titan
Perrigo (NYSE: PRGO) director gains shares through RSU grant and vesting - Stock Titan
Perrigo (NYSE: PRGO) director granted 16,681 RSUs and exercises 7,305 units - Stock Titan
Perrigo (PRGO) director logs RSU grant, vesting and tax share disposition - Stock Titan
Perrigo (PRGO) director reports RSU grant, exercise and tax-withholding share disposition - Stock Titan
Perrigo (PRGO) director Orlando Ashford exercises 10,669 RSUs and withholds 5,122 shares for taxes - Stock Titan
Perrigo (PRGO) director reports RSU grant, share conversion and tax withholding - Stock Titan
Perrigo (NYSE: PRGO) director logs RSU grant, vesting and tax share disposition - Stock Titan
Perrigo (NYSE: PRGO) director amends Form 4 for RSU tax withholding - Stock Titan
Perrigo reaffirms 2026 outlook, targets $60M-$80M cost savings as results shift to 2H - MSN
Compeed Blasenpflaster: Advanced Blister Protection for Active Lifestyles - AD HOC NEWS
Perrigo Co. PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Perrigo to Buy Elan for $8.6 Billion - AOL.com
Perrigo Co. PLC stock underperforms Monday when compared to competitors - MarketWatch
Responsive Playbooks and the PRGO Inflection - Stock Traders Daily
Vanguard Group Inc. Buys 1,101,154 Shares of Perrigo Company plc $PRGO - MarketBeat
Perrigo Company plc (NYSE:PRGO) Q1 2026 Earnings Call Transcript - Insider Monkey
Perrigo Shareholders Endorse Directors, Pay and Capital Flexibility - TipRanks
Perrigo Co. PLC stock underperforms Thursday when compared to competitors - MarketWatch
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y - The Globe and Mail
Perrigo (PRGO) Q1 2026 Earnings Transcript - AOL.com
T. Rowe Price holds 14.0M Perrigo shares (PRGO) in Schedule 13G/A - Stock Titan
T. Rowe Price (PRGO) discloses 13.38M shares; Mid‑Cap Value Fund holds 7.50M - Stock Titan
Assessing Perrigo (PRGO) Valuation After Weak Q1 Results And Lowered Guidance - Yahoo Finance
Jefferies lowers Perrigo stock price target to $14 on weak quarter By Investing.com - Investing.com Australia
Perrigo Company plc Q1 2026 Earnings Call Summary - Yahoo Finance
Perrigo Q1 2026 slides: EPS beats amid market softness, shares gain - Investing.com Australia
Silicone Scar Treatment Products Market 2026- 2033 Overview: - openPR.com
Jefferies lowers Perrigo stock price target to $14 on weak quarter - Investing.com Nigeria
MSN Money - MSN
Perrigo Q1 2026 Earnings Call Transcript - MarketBeat
Perrigo Earnings: While 2026 Expectations Are Low, Recovery Is Playing Out as Expected - Morningstar
Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch
Goodwill impairments drive Perrigo (NYSE: PRGO) to deep quarterly loss - Stock Titan
Perrigo Company Releases Q1 2026 Financial Results - AlphaStreet
Perrigo Company plc 2026 Q1ResultsEarnings Call Presentation (NYSE:PRGO) 2026-05-06 - Seeking Alpha
Perrigo to lay off 161 as company heads toward Vermont site closure - VTDigger
Earnings call transcript: Perrigo Q1 2026 beats EPS estimates, stock rises - Investing.com Australia
Perrigo Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Perrigo Fiscal Q1 Adjusted Earnings, Net Sales Decline - marketscreener.com
Perrigo Company Plc Stock (PRGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):